|
2025 Journal Article Evolution of KoRV-A transcriptional silencing in wild koalasYu, Tianxiong, Blyton, Michaela B.J., Abajorga, Milky, Koppetsch, Birgit S., Ho, Samantha, Xu, Bo, Hu, Zhongren, Luban, Jeremy, Chappell, Keith, Weng, Zhiping and Theurkauf, William E. (2025). Evolution of KoRV-A transcriptional silencing in wild koalas. Cell. doi: 10.1016/j.cell.2025.02.006 |
|
2024 Journal Article HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitorsTardiota, Nicolas, Jaberolansar, Noushin, Lackenby, Julia A., Chappell, Keith J. and O’Donnell, Jake S. (2024). HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors. Virology Journal, 21 (1) 14. doi: 10.1186/s12985-024-02288-z |
|
2024 Journal Article Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe diseaseO’Donnell, Jake S., Jaberolansar, Noushin and Chappell, Keith J. (2024). Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease. The Lancet Microbe, 5 (4), e400-e408. doi: 10.1016/s2666-5247(23)00359-2 |
|
2023 Journal Article The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 gamma variantPegg, Cassandra L., Modhiran, Naphak, Parry, Rhys H., Liang, Benjamin, Amarilla, Alberto A., Khromykh, Alexander A., Burr, Lucy, Young, Paul R., Chappell, Keith, Schulz, Benjamin L. and Watterson, Daniel (2023). The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 gamma variant. Glycobiology, 34 (2) cwad097, 1-13. doi: 10.1093/glycob/cwad097 |
|
2023 Journal Article Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18–55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trialChappell, Keith J., Mordant, Francesca L., Amarilla, Alberto A., Modhiran, Naphak, Liang, Benjamin, Li, Zheyi, Wijesundara, Danushka K., Lackenby, Julia A., Griffin, Paul, Bennet, Jillian K., Hensen, Luca, Zhang, Wuji, Nguyen, Thi H.O., Tran, Mai H., Tapley, Peter, Barnes, James, Reading, Patrick C., Kedzierska, Katherine, Ranasinghe, Charani, Subbarao, Kanta, Watterson, Daniel, Young, Paul R. and Munro, Trent P. (2023). Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18–55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial. eBioMedicine, 97 104842. doi: 10.1016/j.ebiom.2023.104842 |
|
2023 Journal Article Broad protection from SARS-CoV-2 variants without antigen matchingChappell, Keith (2023). Broad protection from SARS-CoV-2 variants without antigen matching. The Lancet Respiratory Medicine, 11 (11), 947-948. doi: 10.1016/S2213-2600(23)00290-4 |
|
2023 Journal Article A nanobody recognizes a unique conserved epitope and potently neutralizes against the SARS-CoV-2 omicron variantsModhiran, Naphak, Lauer, Simon Malte, Amarilla, Alberto A., Hewins, Peter, Lopes van den Broek, Sara Irene, Low, Yu Shang, Thakur, Nazia, Liang, Benjamin, Nieto, Guillermo Valenzuela, Jung, James, Paramitha, Devina, Isaacs, Ariel, Sng, Julian D. J., Song, David, Jørgensen, Jesper Tranekjær, Cheuquemilla, Yorka, Bürger, Jörg, Andersen, Ida Vang, Himelreichs, Johanna, Jara, Ronald, MacLoughlin, Ronan, Miranda-Chacon, Zaray, Chana-Cuevas, Pedro, Kramer, Vasko, Spahn, Christian M. T., Mielke, Thorsten, Khromykh, Alexander A., Munro, Trent, Jones, Martina L. ... Watterson, Daniel (2023). A nanobody recognizes a unique conserved epitope and potently neutralizes against the SARS-CoV-2 omicron variants. iScience, 26 (7) 107085, 107085. doi: 10.1016/j.isci.2023.107085 |
|
2023 Journal Article Integrated molecular and immunological features of human T-lymphotropic virus type 1 infection and disease progression to adult T-cell leukaemia or lymphomaO'Donnell, Jake S., Hunt, Stewart K. and Chappell, Keith J. (2023). Integrated molecular and immunological features of human T-lymphotropic virus type 1 infection and disease progression to adult T-cell leukaemia or lymphoma. The Lancet Haematology, 10 (7), e539-e548. doi: 10.1016/S2352-3026(23)00087-X |
|
2023 Journal Article Structure and antigenicity of divergent Henipavirus fusion glycoproteinsIsaacs, Ariel, Low, Yu Shang, Macauslane, Kyle L., Seitanidou, Joy, Pegg, Cassandra L., Cheung, Stacey T. M., Liang, Benjamin, Scott, Connor A. P., Landsberg, Michael J., Schulz, Benjamin L., Chappell, Keith J., Modhiran, Naphak and Watterson, Daniel (2023). Structure and antigenicity of divergent Henipavirus fusion glycoproteins. Nature Communications, 14 (1) 3577, 1-10. doi: 10.1038/s41467-023-39278-8 |
|
2023 Journal Article Erratum: Geographic patterns of koala retrovirus genetic diversity, endogenization, and subtype distributions (Proc. Natl. Acad. Sci. U.S.A. (2022) 119 (e2122680119) DOI: 10.1073/pnas.2122680119)Blyton, Michaela D. J., Young, Paul R., Moore, Ben D. and Chappell, Keith J. (2023). Erratum: Geographic patterns of koala retrovirus genetic diversity, endogenization, and subtype distributions (Proc. Natl. Acad. Sci. U.S.A. (2022) 119 (e2122680119) DOI: 10.1073/pnas.2122680119). Proceedings of the National Academy of Sciences of the United States of America, 120 (1) e2220541120. doi: 10.1073/pnas.2220541120 |
|
Featured 2023 Journal Article SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike proteinAlbornoz, Eduardo A., Amarilla, Alberto A., Modhiran, Naphak, Parker, Sandra, Li, Xaria X., Wijesundara, Danushka K., Aguado, Julio, Zamora, Adriana Pliego, McMillan, Christopher L. D., Liang, Benjamin, Peng, Nias Y. G., Sng, Julian D. J., Saima, Fatema Tuj, Fung, Jenny N., Lee, John D., Paramitha, Devina, Parry, Rhys, Avumegah, Michael S., Isaacs, Ariel, Lo, Martin W., Miranda-Chacon, Zaray, Bradshaw, Daniella, Salinas-Rebolledo, Constanza, Rajapakse, Niwanthi W., Wolvetang, Ernst J., Munro, Trent P., Rojas-Fernandez, Alejandro, Young, Paul R., Stacey, Katryn J. ... Woodruff, Trent M. (2023). SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein. Molecular Psychiatry, 28 (7), 2878-2893. doi: 10.1038/s41380-022-01831-0 |
|
2022 Journal Article Diversity and transmission of koala retrovirus: a case study in three captive koala populationsJoyce, Briony A., Blyton, Michaela D. J., Johnston, Stephen D., Meikle, William D., Vinette Herrin, Kimberly, Madden, Claire, Young, Paul R. and Chappell, Keith J. (2022). Diversity and transmission of koala retrovirus: a case study in three captive koala populations. Scientific Reports, 12 (1) 15787, 1-8. doi: 10.1038/s41598-022-18939-6 |
|
2022 Journal Article Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccineO’Donnell, Jake S., Isaacs, Ariel, Jakob, Virginie, Lebas, Celia, Barnes, James B., Reading, Patrick C., Young, Paul R., Watterson, Daniel, Dubois, Patrice M., Collin, Nicolas and Chappell, Keith J. (2022). Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine. Frontiers in Immunology, 13 976968, 976968. doi: 10.3389/fimmu.2022.976968 |
|
2022 Journal Article Editorial: Emerging and re-emerging viral zoonosesKumar, Naveen, Uversky, Vladimir N., Tomar, Shailly, Li, Kenneth S. M., Chappell, Keith and Lau, Susanna K. P. (2022). Editorial: Emerging and re-emerging viral zoonoses. Frontiers in Microbiology, 13 978259, 978259. doi: 10.3389/fmicb.2022.978259 |
|
2022 Journal Article A platform technology for generating subunit vaccines against diverse viral pathogensYoung, Andrew, Isaacs, Ariel, Scott, Connor A. P., Modhiran, Naphak, McMillan, Christopher L. D., Cheung, Stacey T. M., Barr, Jennifer, Marsh, Glenn, Thakur, Nazia, Bailey, Dalan, Li, Kenneth S. M., Luk, Hayes K. H., Kok, Kin-Hang, Lau, Susanna K. P., Woo, Patrick C. Y., Furuyama, Wakako, Marzi, Andrea, Young, Paul R., Chappell, Keith J. and Watterson, Daniel (2022). A platform technology for generating subunit vaccines against diverse viral pathogens. Frontiers in Immunology, 13 963023, 1-16. doi: 10.3389/fimmu.2022.963023 |
|
2022 Journal Article Geographic patterns of koala retrovirus genetic diversity, endogenization, and subtype distributionsBlyton, Michaela D. J., Young, Paul R., Moore, Ben D. and Chappell, Keith J. (2022). Geographic patterns of koala retrovirus genetic diversity, endogenization, and subtype distributions. Proceedings of the National Academy of Sciences, 119 (33) e2122680119, 1-11. doi: 10.1073/pnas.2122680119 |
|
2022 Journal Article Nucleocapsid specific diagnostics for the detection of divergent SARS-CoV-2 variantsIsaacs, Ariel, Amarilla, Alberto A., Aguado, Julio, Modhiran, Naphak, Albornoz, Eduardo A., Baradar, Alireza A., McMillan, Christopher L. D., Choo, Jovin J. Y., Idris, Adi, Supramaniam, Aroon, McMillan, Nigel A. J., Muller, David A., Young, Paul R., Woodruff, Trent M., Wolvetang, Ernst J., Chappell, Keith J. and Watterson, Daniel (2022). Nucleocapsid specific diagnostics for the detection of divergent SARS-CoV-2 variants. Frontiers in Immunology, 13 926262, 926262. doi: 10.3389/fimmu.2022.926262 |
|
2022 Journal Article Koala retrovirus load and non-A subtypes are associated with secondary disease among wild northern koalasBlyton, Michaela D. J., Pyne, Michael, Young, Paul and Chappell, Keith (2022). Koala retrovirus load and non-A subtypes are associated with secondary disease among wild northern koalas. PLoS Pathogens, 18 (5) e1010513, 1-20. doi: 10.1371/journal.ppat.1010513 |
|
2022 Journal Article Peptide-based vaccine against SARS-CoV-2: peptide antigen discovery and screening of adjuvant systemsShalash, Ahmed O., Azuar, Armira, Madge, Harrison Y. R., Modhiran, Naphak, Amarilla, Alberto A., Liang, Benjamin, Khromykh, Alexander A., Hussein, Waleed M., Chappell, Keith J., Watterson, Daniel, Young, Paul R., Skwarczynski, Mariusz and Toth, Istvan (2022). Peptide-based vaccine against SARS-CoV-2: peptide antigen discovery and screening of adjuvant systems. Pharmaceutics, 14 (4) 856, 856. doi: 10.3390/pharmaceutics14040856 |
|
2022 Journal Article Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A virusesMcMillan, Christopher L. D., Cheung, Stacey T. M., Modhiran, Naphak, Barnes, James, Amarilla, Alberto A., Bielefeldt-Ohmann, Helle, Lee, Leo Yi Yang, Guilfoyle, Kate, van Amerongen, Geert, Stittelaar, Koert, Jakob, Virginie, Lebas, Celia, Reading, Patrick, Short, Kirsty R., Young, Paul R., Watterson, Daniel and Chappell, Keith J. (2022). Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses. npj Vaccines, 7 (1) 3, 3. doi: 10.1038/s41541-021-00428-y |
